Materias dentro de su búsqueda.
Mostrando 68,541 - 68,560 Resultados de 68,694 Para Buscar 'Funny OR Die', tiempo de consulta: 0.42s Limitar resultados
  1. 68541
    “…The entry WHO scores were 1–3 in 445 (44%) participants, 4–5 in 529 (52%) participants, and 6 in 38 (4%) participants; and of all participants, 119 died and 271 had disease progression. The odds ratio (OR) associated with COV50 in all 1012 participants for death was 2·44 (95% CI 2·05–2·92) unadjusted and 1·67 (1·34–2·07) when adjusted for sex, age, BMI, comorbidities, and baseline WHO score; and for disease progression, the OR was 1·79 (1·60–2·01) when unadjusted and 1·63 (1·41–1·91) when adjusted (p<0·0001 for all). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study
  2. 68542
    “…We restricted our analysis to residents of California who were aged 18–65 years at time of death and died of natural causes. We classified the occupational sector into nine essential sectors; non-essential; or unemployed or without an occupation provided on the death certificate. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 mortality and excess mortality among working-age residents in California, USA, by occupational sector: a longitudinal cohort analysis of mortality surveillance data
  3. 68543
    “…At least one dose of study treatment was given to 364 (99%) patients (safety analysis set). 54 patients (31%) of 177 in the vilobelimab group and 77 patients (40%) of 191 in the placebo group died in the first 28 days. The all-cause mortality rate at 28 days was 32% (95% CI 25–39) in the vilobelimab group and 42% (35–49) in the placebo group (hazard ratio 0·73, 95% CI 0·50–1·06; p=0·094). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
  4. 68544
    “…A total of 271 (70.6%) patients were discharged home with total or partial improvement and 113 (29.4%) patients died during hospitalization. In-hospital mortality among HIV-positive, SOT, and NHNT patients was 30.3% (92/304), 12.5% (2/16), and 29.7% (19/64), respectively. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    P485 Hiv-positive, solid organ transplant (SOT), and non-Hiv-positive/non-transplant (NHNT) associated with cryptococcosis in Brazil: First national multicenter cohort study
  5. 68545
    “…Seven (6%) of 125 patients had severe malaria, which was often accompanied by anaemia that was unrelated to fexinidazole. One patient died following dyspnoea and injury due to traumatic aggression 172 days after end of treatment, which was considered unrelated to fexinidazole or gambiense human African trypanosomiasis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2–3 trial
  6. 68546
    “…RESULTS: Among the total of 194 patients, 24 patients died and 45 new MACE occurred during a mean 35.2-month follow-up period. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The impact of chronic pre-dialysis hyponatremia on clinical outcomes in maintenance hemodialysis patients
  7. 68547
    “…Mortality was increased in the HFpEF-T3high comparing with the other groups (no animals died during the protocol in the Lean-Ctrl, HFpEF-Ctrl and HFpEF-T3low groups; three animals had sudden death in the HFpEF-T3high group). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    OR19-2 Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) with Low and High Dose of Triiodothyronine: an Animal Model of Metabolic Syndrome with HFpEF
  8. 68548
    “…After linkage, 1 010 871 records were excluded due to missing data on maternal race or skin colour or inconsistent date of death. 19 515 843 livebirths were classified by mother's race, of which 224 213 died. Compared with children of White mothers, mortality risk for children younger than age 5 years was higher among children of Indigenous (HR 1·98 [95% CI 1·92–2·06]), Black (HR 1·39 [1·36–1·41]), and Brown or Mixed race (HR 1·19 [1·18–1·20]) mothers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ethnoracial inequalities and child mortality in Brazil: a nationwide longitudinal study of 19 million newborn babies
  9. 68549
    “…RESULTS: Regarding primary outcome, 10 (33.3%) patients died in intervention group compared to 13 (43.3%) in placebo. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy of intravenous vitamin C in management of moderate and severe COVID-19: A double blind randomized placebo controlled trial
  10. 68550
    “…RESULTS: One-hundred four participants (53/571 [9%] on placebo and 51/1634 [3%] on mAb) died or were hospitalized through day 28. Median AN RNA levels were lower at day 3 compared to day 0 in both placebo (2.5 vs 4.0 log(10) copies/mL [cp/mL]) and mAb (2.3 vs 4.9) groups. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    878. Association between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death for Non-Hospitalized Adults with Mild-to-Moderate COVID-19
  11. 68551
    “…The 5-year disease-free survival, loco-regional recurrence-free survival, distant-metastasis recurrence-free survival was 80.5%, 90.3%, and 88.0%, respectively. Four of the patients died of the disease, and the 5-year overall survival was 92.1%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study
  12. 68552
    “…At data cut-off, April 30, 2020, five (13%) of 40 patients were alive, and 35 (88%) patients had died of progressive disease. At a median follow-up of 52 months (IQR 49–53), median overall survival was 16·5 months (95% CI 13·7–19·2). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study
  13. 68553
    por Garassino, Marina Chiara, Whisenant, Jennifer G, Huang, Li-Ching, Trama, Annalisa, Torri, Valter, Agustoni, Francesco, Baena, Javier, Banna, Giuseppe, Berardi, Rossana, Bettini, Anna Cecilia, Bria, Emilio, Brighenti, Matteo, Cadranel, Jacques, De Toma, Alessandro, Chini, Claudio, Cortellini, Alessio, Felip, Enriqueta, Finocchiaro, Giovanna, Garrido, Pilar, Genova, Carlo, Giusti, Raffaele, Gregorc, Vanesa, Grossi, Francesco, Grosso, Federica, Intagliata, Salvatore, La Verde, Nicla, Liu, Stephen V, Mazieres, Julien, Mercadante, Edoardo, Michielin, Olivier, Minuti, Gabriele, Moro-Sibilot, Denis, Pasello, Giulia, Passaro, Antonio, Scotti, Vieri, Solli, Piergiorgio, Stroppa, Elisa, Tiseo, Marcello, Viscardi, Giuseppe, Voltolini, Luca, Wu, Yi-Long, Zai, Silvia, Pancaldi, Vera, Dingemans, Anne-Marie, Van Meerbeeck, Jan, Barlesi, Fabrice, Wakelee, Heather, Peters, Solange, Horn, Leora
    Publicado 2020
    “…FINDINGS: Between March 26 and April 12, 2020, 200 patients with COVID-19 and thoracic cancers from eight countries were identified and included in the TERAVOLT registry; median age was 68·0 years (61·8–75·0) and the majority had an Eastern Cooperative Oncology Group performance status of 0–1 (142 [72%] of 196 patients), were current or former smokers (159 [81%] of 196), had non-small-cell lung cancer (151 [76%] of 200), and were on therapy at the time of COVID-19 diagnosis (147 [74%] of 199), with 112 (57%) of 197 on first-line treatment. 152 (76%) patients were hospitalised and 66 (33%) died. 13 (10%) of 134 patients who met criteria for ICU admission were admitted to ICU; the remaining 121 were hospitalised, but were not admitted to ICU. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
  14. 68554
    por Ozturk, Savas, Turgutalp, Kenan, Arici, Mustafa, Odabas, Ali Riza, Altiparmak, Mehmet Riza, Aydin, Zeki, Cebeci, Egemen, Basturk, Taner, Soypacaci, Zeki, Sahin, Garip, Elif Ozler, Tuba, Kara, Ekrem, Dheir, Hamad, Eren, Necmi, Suleymanlar, Gultekin, Islam, Mahmud, Ogutmen, Melike Betul, Sengul, Erkan, Ayar, Yavuz, Dolarslan, Murside Esra, Bakirdogen, Serkan, Safak, Seda, Gungor, Ozkan, Sahin, Idris, Mentese, Ilay Berke, Merhametsiz, Ozgur, Oguz, Ebru Gok, Genek, Dilek Gibyeli, Alpay, Nadir, Aktas, Nimet, Duranay, Murat, Alagoz, Selma, Colak, Hulya, Adibelli, Zelal, Pembegul, Irem, Hur, Ender, Azak, Alper, Taymez, Dilek Guven, Tatar, Erhan, Kazancioglu, Rumeyza, Oruc, Aysegul, Yuksel, Enver, Onan, Engin, Turkmen, Kultigin, Hasbal, Nuri Baris, Gurel, Ali, Yelken, Berna, Sahutoglu, Tuncay, Gok, Mahmut, Seyahi, Nurhan, Sevinc, Mustafa, Ozkurt, Sultan, Sipahi, Savas, Bek, Sibel Gokcay, Bora, Feyza, Demirelli, Bulent, Oto, Ozgur Akin, Altunoren, Orcun, Tuglular, Serhan Zubeyde, Demir, Mehmet Emin, Ayli, Mehmet Deniz, Huddam, Bulent, Tanrisev, Mehmet, Bozaci, Ilter, Gursu, Meltem, Bakar, Betul, Tokgoz, Bulent, Tonbul, Halil Zeki, Yildiz, Alaattin, Sezer, Siren, Ates, Kenan
    Publicado 2020
    “…A total of 172/1210 (14.2%) patients died. The ICU admission and in-hospital mortality rates in the CKD group [114/289 (39.4%); 95% confidence interval (CI) 33.9–45.2; and 82/289 (28.4%); 95% CI 23.9–34.5)] were significantly higher than the other groups: HD = 99/390 (25.4%; 95% CI 21.3–29.9; P < 0.001) and 63/390 (16.2%; 95% CI 13.0–20.4; P < 0.001); RT = 17/81 (21.0%; 95% CI 13.2–30.8; P = 0.002) and 9/81 (11.1%; 95% CI 5.7–19.5; P = 0.001); and control = 36/450 (8.0%; 95% CI 5.8–10.8; P < 0.001) and 18/450 (4%; 95% CI 2.5–6.2; P < 0.001). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey
  15. 68555
    por Aftab, Fahad, Ahmed, Imran, Ahmed, Salahuddin, Ali, Said Mohammed, Amenga-Etego, Seeba, Ariff, Shabina, Bahl, Rajiv, Baqui, Abdullah H., Begum, Nazma, Bhutta, Zulfiqar A., Biemba, Godfrey, Cousens, Simon, Das, Vinita, Deb, Saikat, Dhingra, Usha, Dutta, Arup, Edmond, Karen, Esamai, Fabian, Ghosh, Amit Kumar, Gisore, Peter, Grogan, Caroline, Hamer, Davidson H., Herlihy, Julie, Hurt, Lisa, Ilyas, Muhammad, Jehan, Fyezah, Juma, Mohammed Hamad, Kalonji, Michel, Khanam, Rasheda, Kirkwood, Betty R., Kumar, Aarti, Kumar, Alok, Kumar, Vishwajeet, Manu, Alexander, Marete, Irene, Mehmood, Usma, Minckas, Nicole, Mishra, Shambhavi, Mitra, Dipak K., Moin, Mamun Ibne, Muhammad, Karim, Newton, Sam, Ngaima, Serge, Nguwo, Andre, Nisar, Muhammad Imran, Otomba, John, Quaiyum, Mohammad Abdul, Sarrassat, Sophie, Sazawal, Sunil, Semrau, Katherine E., Shannon, Caitlin, Singh, Vinay Pratap, Soofi, Sajid, Soremekun, Seyi, Suleiman, Atifa Mohammed, Sunday, Venantius, Dilip, Thandassery R., Tshefu, Antoinette, Wasan, Yaqub, Yeboah-Antwi, Kojo, Yoshida, Sachiyo, Zaidi, Anita K.
    Publicado 2021
    “…Enrolled women whose pregnancy lasted at least 28 weeks or those who died during pregnancy were included in the analysis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Direct maternal morbidity and the risk of pregnancy-related deaths, stillbirths, and neonatal deaths in South Asia and sub-Saharan Africa: A population-based prospective cohort study in 8 countries
  16. 68556
    por Budhiraja, Sandeep, Tarai, Bansidhar, Jain, Dinesh, Aggarwal, Mona, Indrayan, Abhaya, Das, Poonam, Mishra, Ram Shankar, Bali, Supriya, Mahajan, Monica, Kirtani, Jay, Tickoo, Rommel, Soni, Pankaj, Nangia, Vivek, Lall, Ajay, Kishore, Nevin, Jain, Ashish, Singh, Omender, Singh, Namrita, Kumar, Ashok, Saxena, Prashant, Dewan, Arun, Aggarwal, Ritesh, Mehra, Mukesh, Jain, Meenakshi, Nakra, Vimal, Sharma, Bhagwan Das, Pandey, Praveen Kumar, Singh, Yogendra Pal, Arora, Vijay, Jain, Suchitra, Chhabra, Ranjana, Tuli, Preeti, Boobna, Vandana, Joshi, Alok, Aggarwal, Manoj, Gupta, Rajiv, Aneja, Pankaj, Dhall, Sanjay, Arora, Vineet, Chugh, Inder Mohan, Garg, Sandeep, Mittal, Vikas, Gupta, Ajay, Jyoti, Bikram, Sharma, Puneet, Bhasin, Pooja, Jain, Shakti, Singhal, Rajinder Kumar, Bhasin, Atul, Vardani, Anil, Pal, Vivek, Pande, Deepak Gargi, Gulati, Tribhuvan, Nayar, Sandeep, Kalra, Sunny, Garg, Manish, Pande, Rajesh, Bag, Pradyut, Gupta, Arpit, Sharma, Jitin, Handoo, Anil, Burman, Purabi, Gupta, Ajay Kumar, Choudhary, Pankaj Nand, Gupta, Ashish, Gupta, Puneet, Joshi, Sharad, Tayal, Nitesh, Gupta, Manish, Khanna, Anita, Kishore, Sachin, Sahay, Shailesh, Dang, Rajiv, Mishra, Neelima, Sekhri, Sunil, Srivastava, Rajneesh Chandra, Agrawal, Mitali Bharat, Mathur, Mohit, Banwari, Akash, Khetarpal, Sumit, Pandove, Sachin, Bhasin, Deepak, Singh, Harpal, Midha, Devender, Bhutani, Anjali, Kaur, Manpreet, Singh, Amarjit, Sharma, Shalini, Singla, Komal, Gupta, Pooja, Sagar, Vinay, Dixit, Ambrish, Bajpai, Rashmi, Chachra, Vaibhav, Tyagi, Puneet, Saxena, Sanjay, Uniyal, Bhupesh, Belwal, Shantanu, Aier, Imliwati, Singhal, Mini, Khaduri, Ankit
    Publicado 2022
    “…Only 1.2% of patients with SIs with mild COVID-19 at admission died, compared with 17.5% of those with moderate COVID-19 at admission and 58.5% of those with severe COVID-19 at admission (P<0.001). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Secondary infections modify the overall course of hospitalized patients with COVID-19: a retrospective study from a network of hospitals across North India
  17. 68557
    por Ildefons Magrans de Abril
    Publicado 2008
    “…Therefore, the clientis not automatically informed if the cell dies, and it is the client’s responsibility to implement a time-out or aperiodic “ping” routine to check that the cell is still alive.library. …”
    Enlace del recurso
    The CMS Trigger Supervisor: Control and Hardware Monitoring System of the CMS Level-1 Trigger at CERN
  18. 68558
    “…Among all 710 IEIs pediatric cases who acquired SARS-CoV-2, some children were documented to be admitted to the intensive care unit (ICU) (n = 119, 16.8%), intubated and placed on mechanical ventilation (n = 87, 12.2%), suffered acute respiratory distress syndrome (n = 98, 13.8%) or died (n = 60, 8.4%). Overall, COVID-19 in children with different IEIs patents resulted in no or low severity of disease in more than 76% of all included cases (COVID-19 severity: asymptomatic = 105, mild = 351, or moderate = 88). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review
  19. 68559
    por Jacobs, Ian J, Menon, Usha, Ryan, Andy, Gentry-Maharaj, Aleksandra, Burnell, Matthew, Kalsi, Jatinderpal K, Amso, Nazar N, Apostolidou, Sophia, Benjamin, Elizabeth, Cruickshank, Derek, Crump, Danielle N, Davies, Susan K, Dawnay, Anne, Dobbs, Stephen, Fletcher, Gwendolen, Ford, Jeremy, Godfrey, Keith, Gunu, Richard, Habib, Mariam, Hallett, Rachel, Herod, Jonathan, Jenkins, Howard, Karpinskyj, Chloe, Leeson, Simon, Lewis, Sara J, Liston, William R, Lopes, Alberto, Mould, Tim, Murdoch, John, Oram, David, Rabideau, Dustin J, Reynolds, Karina, Scott, Ian, Seif, Mourad W, Sharma, Aarti, Singh, Naveena, Taylor, Julie, Warburton, Fiona, Widschwendter, Martin, Williamson, Karin, Woolas, Robert, Fallowfield, Lesley, McGuire, Alistair J, Campbell, Stuart, Parmar, Mahesh, Skates, Steven J
    Publicado 2016
    “…Of these women, 148 (0·29%) women in the MMS group, 154 (0·30%) in the USS group, and 347 (0·34%) in the no screening group had died of ovarian cancer. The primary analysis using a Cox proportional hazards model gave a mortality reduction over years 0–14 of 15% (95% CI −3 to 30; p=0·10) with MMS and 11% (−7 to 27; p=0·21) with USS. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
  20. 68560
    “…Compared with the COVID-19 neurology group, more patients in the PIMS-TS neurology group were admitted to intensive care (20 [80%] of 25 patients vs six [22%] of 27 patients, p=0·0001) and received immunomodulatory treatment (22 [88%] patients vs 12 [44%] patients, p=0·045). 17 (33%) patients (10 [37%] in the COVID-19 neurology group and 7 [28%] in the PIMS-TS neurology group) were discharged with disability; one (2%) died (who had stroke, in the PIMS-TS neurology group). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study
Herramientas de búsqueda: RSS